Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Multi-Center Study to Evaluate Treatment of Subjects With Occlusive Disease With a Novel Paclitaxel-Coated Angioplasty Balloon in Below-The-Knee (BTK) Arteries

NCT03175744 is registered in ClinicalTrials.gov with Spectranetics Corporation as lead sponsor.

NCT NCT03175744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03175744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Multi-Center Study to Evaluate Treatment of Subjects With Occlusive Disease With a Novel Paclitaxel-Coated Angioplasty Balloon in Below-The-Knee (BTK) Arteries
Lead sponsor
Spectranetics Corporation
Phase
Not applicable
Overall status
Suspended
Start date
May 24, 2017
Completion date
October 31, 2025
Enrollment
82 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia